Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 26/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2025-1-4

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and Pyrazinamide treatment group.

Abundance in Group 1: increased abundance in Z (Pyrazinamide)

NCBI	Quality Control	Links
Acetanaerobacterium
Acetatifactor
Acetivibrio
Akkermansia
Alistipes
Anaeroplasma
Anaerosporobacter
Anaerotruncus
Arthrobacter
Bacteroides
Blautia
Christensenella
Coprobacter
Dorea
Dysgonomonas
Eisenbergiella
Enterorhabdus
Erysipelothrix
Erysipelotrichaceae
Ethanoligenens
Flavonifractor
Gordonibacter
Guggenheimella
Hydrogenoanaerobacterium
Intestinimonas
Lachnospiraceae
Marvinbryantia
Mucispirillum
Oscillibacter
Oxobacter
Pelotomaculum
Pseudobacteroides
Pseudoflavonifractor
Robinsoniella
Romboutsia
Roseburia
Ruminococcus
Stomatobaculum
Tannerella
Thomasclavelia
Turicibacter
Tyzzerella
Eubacterium

Revision editor(s): KateRasheed